FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Professur für Molekulare Mechanismen der Organfibrose
Reallocation / Closing: 30.09.2022
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Department of Medicine 3 – Rheumatology and Immunology
Lehrstuhl für Innere Medizin III
Overview
Publications
(354)
Research Grants
(2)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Engrailed 1 coordinates cytoskeletal reorganization to induce myofibroblast differentiation (2021)
Györfi AH, Matei AE, Fuchs M, Liang C, Rigau A, Hong X, Zhu H, et al.
Journal article
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort (2021)
Hernández J, Jordan S, Dobrota R, Iudici M, Hasler P, Ribi C, Villiger P, et al.
Journal article
Quantification of Ga-68-FAPI-04 in systemic sclerosis-associated interstitial lung disease Reply (2021)
Distler J, Bergmann C, Kuwert T, Schmidkonz C
Journal article, Letter
Quantification of 68Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease – Authors' reply (2021)
Distler J, Bergmann C, Kuwert T, Schmidkonz C
Journal article
Targeting human plasmacytoid dendritic cells through BDCA2 prevents skin inflammation and fibrosis in a novel xenotransplant mouse model of scleroderma (2021)
Ross RL, Corinaldesi C, Migneco G, Carr IM, Antanaviciute A, Wasson CW, Carriero A, et al.
Journal article
Digital pitting scars are associated with a severe disease course and death in systemic sclerosis: a study from the EUSTAR cohort (2021)
Hughes M, Heal C, Henes J, Balbir-Gurman A, Distler J, Airo P, Mueller-Ladner U, et al.
Journal article
Bone Morphogenetic Protein Antagonist Gremlin-1 Increases Myofibroblast Transition in Dermal Fibroblasts: Implications for Systemic Sclerosis (2021)
Duffy L, Henderson J, Brown M, Pryzborski S, Fullard N, Summa L, Distler J, et al.
Journal article
ENGRAILED 1 COORDINATES CYTOSKELETAL ORGANIZATION TO PROMOTE MYOFIBROBLAST DIFFERENTIATION AND FIBROTIC TISSUE REMODELING (2021)
Györfi AH, Matei AE, Fuchs M, Rigau A, Hong X, Honglin Z, Luber M, et al.
Conference contribution
DYNAMIC CHANGES IN O-GLCNACYLATION REGULATE OSTEOCLAST DIFFERENTIATION AND BONE LOSS IN ARTHRITIS (2021)
Chen CW, Li YN, Trinh MT, Honglin Z, Matei AE, Ding X, TRAN MANH C, et al.
Conference contribution
ANTI-S100A4 MONOCLONAL ANTIBODY TREATMENT AMELIORATES SKIN FIBROSIS IN INFLAMMATORY AND NON-INFLAMMATORY PRE-CLINICAL MODELS OF SYSTEMIC SCLEROSIS (2021)
Tomcik M, Trinh MT, Trinh-Minh T, TRAN MANH C, Storkanova H, Storkanova L, Senolt L, et al.
Conference contribution
‹
1
...
5
6
7
8
9
...
35
›